Published in Lung on November 25, 2015
Prognostic value of high IMP3 expression in solid tumors: a meta-analysis. Onco Targets Ther (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart. J Thorac Oncol (2015) 5.83
A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol (1999) 5.58
The incidences and mortalities of major cancers in China, 2009. Chin J Cancer (2013) 5.17
Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene (1997) 2.58
RNA-binding IMPs promote cell adhesion and invadopodia formation. EMBO J (2006) 2.34
The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells. J Biol Chem (2005) 1.94
IMP3 predicts aggressive superficial urothelial carcinoma of the bladder. Clin Cancer Res (2008) 1.87
Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? Cell Mol Life Sci (2012) 1.68
Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study. Lancet Oncol (2006) 1.61
External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma. Cancer (2008) 1.45
RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma. Hepatology (2008) 1.43
IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis. Ann Surg Oncol (2009) 1.29
International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women. Lung Cancer (2014) 1.28
The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma. Am J Surg Pathol (2008) 1.26
The use of insulin like-growth factor II messenger RNA binding protein-3 in diagnostic pathology. Hum Pathol (2010) 1.06
Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas. Cancer (2008) 1.05
Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma. Ann Surg Oncol (2009) 1.03
IMP3 can predict aggressive behaviour of lung adenocarcinoma. Diagn Pathol (2012) 1.03
Mixed adenocarcinomas of the lung: place in new proposals in classification, mandatory for target therapy. Arch Pathol Lab Med (2010) 1.03
Worldwide trend of increasing primary adenocarcinoma of the lung. Surg Today (2013) 1.00
RNA-binding protein insulin-like growth factor mRNA-binding protein 3 (IMP-3) promotes cell survival via insulin-like growth factor II signaling after ionizing radiation. J Biol Chem (2011) 0.98
IMP3 expression is correlated with histologic grade of lung adenocarcinoma. Hum Pathol (2009) 0.94
Insulin-like growth factor II-messenger RNA-binding protein-3 and lung cancer. Biotech Histochem (2011) 0.92
IMP3 expression in non-small cell lung cancer. Hum Pathol (2009) 0.90
Phase I Trial of sequential administration of recombinant DNA and adenovirus expressing L523S protein in early stage non-small-cell lung cancer. Mol Ther (2006) 0.88
Subtyping lung adenocarcinoma according to the novel 2011 IASLC/ATS/ERS classification: correlation with patient prognosis. Thorac Surg Clin (2013) 0.87
Post-transcriptional regulation of cyclins D1, D3 and G1 and proliferation of human cancer cells depend on IMP-3 nuclear localization. Oncogene (2013) 0.86
IMP3 expression is associated with poor survival in cervical squamous cell carcinoma. Hum Pathol (2014) 0.86
Functional invadopodia formation through stabilization of the PDPN transcript by IMP-3 and cancer-stromal crosstalk for PDPN expression. Carcinogenesis (2012) 0.85
Oncofetal protein IMP3, a new cancer biomarker. Adv Anat Pathol (2014) 0.84
The involvement of insulin-like growth factor 2 binding protein 3 (IMP3) in pancreatic cancer cell migration, invasion, and adhesion. BMC Cancer (2015) 0.83
Clinic significance of microRNA-99a expression in human lung adenocarcinoma. J Surg Oncol (2013) 0.83
IMP3 expression is associated with epithelial-mesenchymal transition in breast cancer. Int J Clin Exp Pathol (2014) 0.81